This Week in Cardiology

Jan 17 2025 This Week in Cardiology

Jan 17, 2025
This week delves into the promising role of renal denervation and the FINEARTS trial results for finerenone in heart failure treatment. It raises questions about the effectiveness of current strategies for patients with HFpEF. The discussion also includes critical reflections on cardiovascular research, examining how marketing may sway outcomes. A significant setback in a medical device study adds to the conversation, alongside a critique of observational studies and their reliability in medical publishing.
Ask episode
Chapters
Transcript
Episode notes